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Abstract
Aspergillus fumigatus (Af) and Pseudomonas aeruginosa (Pa) are leading fungal and bacte-
rial pathogens, respectively, in many clinical situations. Relevant to this, their interface and
co-existence has been studied. In some experiments in vitro, Pa products have been
defined that are inhibitory to Af. In some clinical situations, both can be biofilm producers,
and biofilm could alter their physiology and affect their interaction. That may be most rele-
vant to airways in cystic fibrosis (CF), where both are often prominent residents.
We have studied clinical Pa isolates from several sources for their effects on Af, including
testing involving their biofilms. We show that the described inhibition of Af is related to the
source and phenotype of the Pa isolate. Pa cells inhibited the growth and formation of Af bio-
film from conidia, with CF isolates more inhibitory than non-CF isolates, and non-mucoid CF
isolates most inhibitory. Inhibition did not require live Pa contact, as culture filtrates were
also inhibitory, and again non-mucoid>mucoid CF>non-CF. Preformed Af biofilm was more
resistant to Pa, and inhibition that occurred could be reproduced with filtrates. Inhibition of
Af biofilm appears also dependent on bacterial growth conditions; filtrates from Pa grown as
biofilm were more inhibitory than from Pa grown planktonically. The differences in Pa shown
from these different sources are consistent with the extensive evolutionary Pa changes that
have been described in association with chronic residence in CF airways, and may reflect
adaptive changes to life in a polymicrobial environment.
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Introduction
Cystic fibrosis (CF) is the result of mutations in the CF transmembrane conductance regulator
affecting epithelial chloride and bicarbonate transport. One result is development of thick
respiratory secretions, which results in airway obstruction and recurrent episodes of lung
inflammation and infection, leading to acute and chronic deterioration of lung function and a
shortened lifespan [1]. The affected persons have defective mucociliary clearance and produc-
tion of thick sticky mucus in which various pathogens can become entrapped. This is a suitable
environment for microbial growth and colonization, and these organisms or their soluble
metabolites contribute to airway inflammation and subsequent damage.
The most common bacterium and fungus infecting these airways are Pseudomonas aerugi-
nosa (Pa) [2] and Aspergillus fumigatus (Af) [3–7], respectively, particularly in the chronically
infected older patients. Pa evolves in CF airways, producing variants, such as those resulting in
mucoid colony types, which are adapted to chronic residence there [2,8,9]. Af is ubiquitous in
ambient air and the environment, and thus can be inhaled and subsequently establish resi-
dency. Both organisms are proficient adapters to environmental stress and relatively resistant
to current antimicrobials. They are suspected as important agents in promoting mucus plug
formation in the airways, and both are known to form biofilms in vitro and in vivo [2,9–20].
Microbes in biofilms have altered metabolism compared to the same organisms growing plank-
tonically, and biofilms provide microbes with protection from host defenses as well as tolerance
to some antimicrobial drugs [21]. The attribution of a role for these microbes in mucus plug-
ging and biofilms stems from the known extracellular production of glycan polymers by Af
[22] and alginate by Pa [2,9,17]. In addition to infection, Af can cause allergic bronchopulmon-
ary aspergillosis in up to 15% of CF patients, a complication that causes repeated acute exacer-
bations, institution of immunosuppressive therapy, and accelerated decline in lung function
[23]. As is the case with Pa, Af also produces secondary metabolites, in the environment as well
as in vivo, which are known tissue toxins and also have immunosuppressive actions on the host
response [24]. Infection with Pa or Af has been associated with a more rapid decline in CF pul-
monary function [17,25–33], with the co-infected patients having the worst prognosis [32,34].
Both pathogens are also important because either can be an opportunist, causing invasive dis-
ease [35–39] or other complications [40,41], in lung transplantation, a therapeutic modality
offered in debilitating CF.
It is therefore important to study the interactions between these two pathogens. Pa-secreted
molecules have been well studied for their antifungal activities, a property that has been dem-
onstrated in vitro [42–47]. These inhibitory molecules include homoserine lactones, pyocyanin
and other phenazine derivates, pyrrolnitrin and fluorescent green pigments. However, these
studies were performed with one or few Pa isolates, none representatives of variants that estab-
lish chronic residency in CF airways. Moreover, Pa-associated factors involved in this inter-
kingdom inhibition continue to be elucidated [48]. The aim of this study was to evaluate the
effect of different clinical Pa phenotypic variants obtained from CF and non-CF patients on Af
biofilm formation and preformed Af biofilm.
Materials and Methods
Isolates
Any CF isolates from patient respiratory cultures were obtained after written informed con-
sent, for biobanking of the patients’ specimens and subsequent use, approved by the Stanford
Institutional Review Board. Other isolates were obtained following clinically indicated cultures.
Twenty-six clinical isolates of Pa recovered from non-CF patients (n = 16 isolates), or CF
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patient sputum (n = 10), from Stanford University Hospital and clinics were evaluated. Among
the CF isolates, five were mucoid colony phenotype variants [2,8,9] and five were non-mucoid
colony phenotype variants. A list of all isolates studied, and their classification, is given in
Tables 1 and 2. We were able to include a mucoid and a non-mucoid Pa isolate obtained from
the same CF patient the same day, 2 non-mucoid Pa isolates from another CF patient 6 mos.
apart, and 2 Pa isolates with different colonial morphologies from each of 2 non-CF patients
obtained the same day, plus another Pa isolate from one of these patients one month later. Af
isolate 10AF, a virulent non-CF patient isolate [49,50], was used as the reference Af isolate
throughout this study. Nine sputum Af isolates, also identified by molecular methods to be Af
sensu stricto [51], were obtained from non-CF patients in a previous study [51] and addition-
ally studied.
Af conidia were obtained as follows: Af was taken from stock suspensions stored at -80°C
and then grown for 4 days on Sabouraud Dextrose Agar (Becton Dickinson and Co., Sparks,
MD) at 37°C. Conidia were harvested by gently washing with 0.05% Tween-80 (J.T. Baker
Chemical Co., Phillipsburg, NJ) in 0.9% saline (Baxter Healthcare Corp., Deerfield, IL).
Pa stocks were maintained at -80°C in Microbank microbial storage vials (Pro-Lab Diagnos-
tics, Richmond Hill, Ontario, Canada). Each frozen Pa stock culture was initially inoculated
onto Trypticase Soy + 5% sheep blood agar plates (TSA; BBL, Becton Dickinson; subsequent
studies indicated the absence of blood in the agar plates did not affect the activity of the Pa har-
vested) and incubated overnight at 37°C. Pa colonies were then picked, 1–2 loopfuls of the bac-
teria diluted in RPMI-1640 medium, and the suspension adjusted in the spectrophotometer at
A610 to an absorbance of 0.35–0.40 with fresh RPMI-1640 medium. This corresponded to 109/
ml, with variation over a 3-fold range. A 1:30 dilution was then made in studies of direct Pa
action on Af biofilm, or production of Pa culture supernatants, to be described. We found, in
the studies to be described, that neither direct Pa action, nor Pa supernatant action, on Af bio-
film was particularly sensitive to the size of the initial Pa inoculum in those studies, as varia-
tions of at least 10-fold in live Pa cells, and at least 33-fold in the inoculum used to make
planktonic Pa supernatants, resulted in no significant differences in activity.
Inhibition of planktonic Af growth
Inhibition of growth was assessed by using a conidial inoculum, following guidelines for sus-
ceptibility testing of filamentous organisms [52].
In vitromodel of biofilm development
Biofilms were formed by using a modified in vitromodel described previously [53]. To form Af
biofilm, sterile polystyrene disks (Biosurface Technologies, Bozeman, MT) were placed in
12-well tissue culture plates (Corning Inc., Corning, NY). Each well contained 3 ml of fresh
RPMI-1640 medium (Lonza, Walkersville, MD) with 105 Af conidia/ml.
Disks were incubated at 37°C for 16 h with shaking at 70 rpm, to allow the fungal cells to
attach. Following the attachment phase, disks were gently rinsed in sterile saline (Baxter
Healthcare Corp.), transferred to new plates containing fresh RPMI-1640 medium, and incu-
bated for an additional 24 h at 37°C with shaking at 100 rpm (Fig 1I). Biofilm formation here,
and in all experimental conditions to be described, was verified by inspection or with a light
microscope [16].
Direct interaction of live Pa on Af biofilm formation
Suspensions of fungal conidia (3 ml) and bacterial cells (0.1 ml), prepared as described above,
were combined in 12-well tissue culture plates in fresh RPMI-1640 medium and incubated at
Aspergillus Biofilm and CF Pseudomonas
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Table 1. Clinical isolates.
Sample
identiﬁcation ID #
CIMR # P. aeruginosa (Pa)
phenotype
Clinical Laboratory ID # Valley Medical Center
(VMC) or Stanford University (SU)
Specimen Date of the positive
Pa culture
1 14–75 Pa Non CF VMC Respiratory 1/28/2013
2 14–76 Pa Non CF VMC Respiratory 2/19/2013
3 14–77 Pa Non CF VMC Respiratory 2/19/2013
4 14–78 Pa Non CF SU 60370871 Respiratory 2/17/2013
9 14–83 Pa Non CF VMC Respiratory 3/17/2013
12 14–86 Pa Non CF SU 42266353 Respiratory 4/22/2013
13 14–87 Pa Non CF (Strain #1) SU 21548242 Respiratory 8/10/2013
14 14–88 Pa Non CF (Strain #2) SU 21548292 Respiratory 8/10/2013
16 14–90 Pa Non CF (Strain #1) SU 27917939 Respiratory 9/24/2013
17 14–91 Pa Non CF (Strain #2) SU 27917939 Respiratory 9/24/2013
19 14–93 Pa Non CF SU 21548292 Respiratory 9/26/2013
20 14–94 Pa Non CF SU 10790053 Non
respiratory
8/14/2013
24 14–98 Pa Non CF SU 41082579 Non
Respiratory
10/02/2013
25 14–99 Pa Non CF (strain #2) SU 22765499 Non
respiratory
9/25/2013
26 14–100 Pa Non CF SU 26308684 Respiratory 9/26/2013
27 14–101 Pa Non CF SU 28674323 Non
respiratory
9/23/2013
5 14–79 Pa CF Mucoid SU 20060455 Respiratory 3/1/2013
11 14–85 Pa CF Mucoid SU 60821238 Respiratory 2/21/2013
18 14–92 Pa CF Mucoid SU 09710807 Respiratory 7/19/2013
21 14–95 Pa CF Mucoid SU 7841943 Respiratory 9/17/2013
22 14–96 Pa CF Mucoid SU 41053570 Respiratory 8/10/2013
7 14–81 Pa CF Non Muc SU 09710807 Respiratory 1/19/2013
8 14–82 Pa CF Non Muc SU 16242976 Respiratory 3/13/2013
10 14–84 Pa CF Non Muc SU 7841943 Respiratory 2/01/2013
15 14–89 Pa CF Non Muc SU 41053570 Respiratory 8/10/2013
23 14–97 Pa CF Non Muc SU 16242976 Respiratory 9/6/2013
doi:10.1371/journal.pone.0134692.t001
Table 2. Aspergillus fumigatus clinical isolates.
Sample identiﬁcation ID # CIMR # A. fumigatus phenotype
1 13–55 CF
2 13–56 CF
3 13–57 CF
4 13–58 CF
5 13–59 CF
6 13–60 CF
7 13–61 CF
8 13–62 CF
9 13–63 CF
10 12–26 Non CF
11 12–30 Non CF
12 12–48 Non CF
doi:10.1371/journal.pone.0134692.t002
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37°C for 16 h with shaking at 70 rpm. Thus, for the 3 x 105 Af /well always involved in biofilm
formation, the ratio of Pa to Af was 3.3 x 107:3 x 105/well. Disks were then rinsed gently with
sterile saline, transferred to new plates containing fresh RPMI-1640 medium, and incubated
for an additional 24 h at 37°C with shaking at 70 rpm (Fig 1II).
Fig 1. Experimental design (full details are provided in Methods). To form Af biofilm, polystyrene disks were placed in tissue culture plates with conidia
and media. Disks were incubated to allow the conidia to attach. Following the attachment phase, disks were transferred to new plates containing and
incubated for an additional 24 h (line I). Direct interaction of live Pa on Af biofilm formation: Suspensions of conidia and bacteria were combined in tissue
culture plates for 16 h. Disks were then rinsed gently, transferred to new plates, and incubated for an additional 24 h (line II). Direct interaction of live Pa on
preformed Af biofilm: Fungal biofilms were formed as described. After 16 h the disks were rinsed, transferred to new plates containing Pa suspension and
incubated an additional 24 h (lines II and IV). Pa planktonic supernatant assay: To obtain planktonic culture filtrates, Pa suspension was incubated in conical
tubes for 24 h. The spent medium was centrifuged to remove suspended cells or debris. The supernatant was filter sterilized and added to wells of a tissue
culture plate previously inoculated with Af suspension. Fungal biofilms attached and formed. Disks containing biofilms were washed, transferred to a new
plate, and incubated for an additional 24 h (line III). For the preformed biofilm assay, filtered supernatant was added to wells. Disks containing Af preformed
biofilms were washed, transferred to the plate containing the bacterial filtrates, and incubated an additional 24 h. Af wells without bacterial supernatant were
included as controls (line V). To obtain Pa biofilm filtrates, a suspension of Pa adhered to tissue culture flasks for 2 h (attachment phase). The flasks were
rinsed, fresh RPMI-1640 added to the flask and adhered cells formed Pa biofilms for 22 h. The spent medium was then removed. Af conidia forming biofilms
or preformed Af biofilms were challenged with the Pa biofilm culture filtrate (lines III and V).
doi:10.1371/journal.pone.0134692.g001
Aspergillus Biofilm and CF Pseudomonas
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Direct interaction of live Pa on preformed (i.e., established) Af biofilm
Fungal biofilms were formed as described above. After 16 h the disks containing the fungal pre-
formed biofilms were rinsed gently in sterile saline, transferred to new plates containing Pa sus-
pension (3 ml containing 3.3 x 107 cells) prepared as described above, and incubated for an
additional 24 h at 37°C with shaking at 70 rpm (Fig 1II and 1IV).
Pa planktonic supernatant assay
A Pa suspension was prepared as described above in fresh RPMI-1640 medium. To obtain the
planktonic culture filtrates, the bacterial suspension in fresh RPMI described above was incu-
bated in 50 ml conical tubes (Falcon, Brookings, So. Dakota) for 24 h at 37°C with shaking at
70 rpm. The spent medium was removed, transferred to a new 50 ml conical tube, and centri-
fuged for 30 min at 2,000 x g to remove any suspended cells or debris. The planktonic superna-
tant was gently removed, filter sterilized (0.22 μm) (Fisherbrand, Pittsburgh, PA) and used.
Filtered supernatant (1.5 ml) was added to selected wells of a 12-well tissue culture plate previ-
ously inoculated with 1.5 ml of the standardized Af suspension in fresh RPMI-1640. Fungal
biofilms attached and formed as described above. Disks containing biofilms were washed 3
times with sterile saline and transferred to a new plate containing fresh RPMI-1640, and incu-
bated for an additional 24 h at 37°C with shaking at 70 rpm (Fig 1III). Although “supernatants”
and “filtrates” are used interchangeably in this paper, when any supernatants were tested they
were always first filtered as described above; unfiltered supernatants were never used.
For the preformed biofilm assay, 1.5 ml of the filtered bacterial supernatant was added to
selected wells of a 12-well tissue culture plate with 1.5 ml of fresh RPMI-1640. Af biofilms were
prepared as described above. Disks containing these fungal preformed biofilms were washed 3
times with sterile saline, transferred to the plate containing the fresh media + the bacterial fil-
trates, and incubated for an additional 24 h at 37°C with shaking at 70 rpm. Af wells without
bacterial supernatant were also included to serve as controls (Fig 1V).
To assay growth during Pa planktonic culture, the Pa planktonic suspension was prepared
as described above, adjusted to 106/ml, incubated as described above, and at the end of the 24
h, serial dilutions of the supernatant were inoculated onto TSA plates, incubated for 24 h at
37°C, and CFU enumerated.
Pa biofilm filtrate assay
To obtain the Pa biofilm filtrates, a 25 ml suspension of Pa prepared as described above,
adhered to 50 ml canted neck tissue culture flasks (BD Biosciences, San Diego) for 2 h at 37°C
on a 100 rpm shaker incubator (attachment phase). The liquid was then removed and the flasks
were rinsed gently 3 times with sterile saline. Twenty ml of fresh RPMI-1640 was added to the
flask and adhered cells formed Pa biofilms for 22 h (total of 24 h), observed by the presence
of a layer of bacterial growth on the inner surface of the flask. The spent medium was then
removed and processed as described above. Af conidia forming biofilms or preformed Af bio-
films were challenged with the Pa biofilm culture filtrate, as described above. Bacterial superna-
tant-free wells were also included as controls (Fig 1III and 1V). Either Pa planktonic or biofilm
supernatants were used when prepared, although studies indicated no change in activity if
stored refrigerated for at least one week.
Studies with serum
For sets of experiments with Af and Pa cultures, to be described, fetal bovine serum (Gibco, Grand
Island, NY) was added to the RPMI-1640 medium at each step to produce a 10% concentration.
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XTT assay
Either when conidia formed biofilm, or when preformed Af biofilm was studied, at the end of
the challenge period with either live Pa cells or filtered Pa cultured supernatants (or control
media), the Af biofilm was studied with the XTT assay. The tetrazolium salt, XTT (2,3-bis
[2-methoxy-4-nitro-5-sulfophenyl]-2H-tetrazolium-5-carboxanilide inner salt) (Sigma,
St. Louis, MO) was used to measure the metabolic activity of Af. XTT is reduced by a mito-
chondrial dehydrogenase to a water-soluble formazan product. Af biofilm discs were rinsed 3
times in sterile saline and transferred to fresh wells containing 3 ml sterile phosphate-buffered
saline (PBS) (pH 7.3–7.5, Lonza). Menadione (Sigma) 0.85 gm was added to 5 ml acetone, and
mixed in a 1:11 ratio of menadione to XTT (1 mg/ml). The XTT-menadione solution (180 μl)
was added to each well and the plates were incubated in the dark for 2 h at 37°C. Following
incubation, the contents of the wells were collected and centrifuged for 10 min at 13,300 x g.
The pellet was then discarded and the absorbance at 490 nm of the supernatant was determined
with a spectrophotometer (Genesys 20, Thermo Scientific, Waltham, MA). Although XTT is a
measure of metabolic activity of cells, previous studies of Af have indicated XTT results are lin-
ear with mass, and equated XTT result with dry weight [54–56].
For the assay of live Pa cells co-incubated with Af, we determined that the XTT readings
only reflected the Af by studying Pa similarly cultured without Af, showing there was no
increase of XTT reduction compared to background without any microbes present.
Confocal laser scanning microscopy (CLSM)
Af biofilms were formed on disks as described above. The biofilms were challenged with Pa
supernatants obtained from a representative of each of the 3 Pa groups. After incubation at
37°C, the disks were washed three times in sterile PBS and stained using a fluorescent stain
(FUN-1; Invitrogen Molecular Probes, Eugene, OR), prepared according to the manufacturer’s
instructions. FUN-1 (1 μl) from a 10 mM stock was mixed in 1 ml of PBS. Staining was per-
formed as previously described [11,13]. Three drops of the mixture were added on the top
of the biofilm, which was then mounted on a glass slide and covered with a glass coverslip
(22 × 22 mm). The disks were incubated for 45 min at 37°C in the dark. The FUN1 visualized
the morphology of Af biofilm, a bright green cytoplasmic stain produced after passive diffu-
sion. An additional analysis was made to visualize the effect of bacterial supernatant on the
fungal biofilm metabolic activity. A red fluorescence, visualized from intravacuolar staining,
was noted, which requires both plasma membrane integrity and metabolic capability (data not
shown). Dead cells would have fluoresced bright yellow-green, with no red structures, and
were not apparent in our images.
Sections on the xy plane were taken at 1 μm intervals along the z-axis to determine the
depth of the biofilms. Microscopic visualization and image acquisition of biofilms were con-
ducted at the Stanford Biofilm Research Center using an upright Leica TCDSP2 scanning con-
focal laser microscope (Leica Lasertechnik GmbH, Heidelberg, Germany) equipped with an
argon/krypton laser and detectors, and filter sets for monitoring of green (excitation 480nm,
emission 517nm) and red (excitation 633nm, emission 676). Images were obtained using a 63 x
1.4 Plan-APOChromat DIC (Leica, Heidelberg, Germany) objectives. Multichannel simulated
fluorescence projection (SFP, a shadow projection) images and vertical cross sections through
the biofilm were generated using the IMARIS software package (Bitplane AG, Zürich, Switzer-
land). Images were processed for display by using Photoshop software (Adobe, Mt. View, CA).
Representative images were taken.
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Dose-response assay of filtrates
A dose response study was performed using one isolate from each of the 3 Pa groups. Pa plank-
tonic and biofilm culture filtrates were obtained as described above. The culture filtrates or
sterile distilled water were diluted in fresh RPMI supplemented with 10% FBS, so that the per-
cent of fresh medium in each test situation was decreased as the spent medium or sterile dis-
tilled water increased. Af biofilms were formed in this mixed media, as described above, or
planktonic Af growth was studied [52].
Effect of temperature on filtrates
The Pa planktonic and biofilm culture filtrates were prepared as described above. In brief, the
final cell-free supernatants were (a) heat treated at 56°C for 30 min and immediately used or
(b) frozen at -80°C, stored for 6 days, and thawed. These filtrates were then tested compared to
fresh filtrates against either Af conidia forming biofilm, or preformed biofilm, as described
above.
Effect of DNase I and Proteinase K on Pa supernatant activity
To determine whether Pa or phage DNA or a Pa protein(s) were involved in the inhibition of
Af, we studied the effect of pretreatment of Pa culture filtrates with DNase I (Life Technologies,
Grand Island, NY) or Proteinase K (Sigma) and measured the filtrate inhibitory activity on Af
biofilm formation (Fig 1I). Pa biofilm culture filtrates were prepared as described using a CF
non-mucoid Pa isolate, Af biofilm metabolic activity was measured using the XTT assay.
Pa culture filtrates were treated with DNase I or Proteinase K for 2 hours at 37°C. Ethylene-
diaminetetraacetic acid disodium salt dehydrate (EDTA) (Sigma) was used to inactivate the
DNase I activity. Experiments with DNase I treatment involved growing the Af for 16 hours in
the presence of (a) Pa filtrate, (b) DNase I (final concentration 2 U/ml) + Pa filtrate, (c) DNase
I + EDTA (final concentration 20mM) + Pa filtrate, (d) EDTA + Pa filtrate, or (e) EDTA alone
or (f) DNase + EDTA (in fresh RPMI medium). These were followed by 24 h growth in fresh
RPMI-1640 alone.
For Proteinase K pretreatment, conidia were incubated with (a) Pa filtrate, (b) Proteinase K
(final concentration 50 μg/ml) + Pa filtrate, or (c) medium treated with Proteinase K.
Materials for other characterization studies
A 30,000 MW cutoff filter was obtained from Millipore Ltd., Tullagreen, Ireland.
Elastolytic production of Pa isolates was assessed as previously described [57].
FeCl3 was obtained from Sigma.
Statistical analyses
Where n is not stated, each experiment was performed at least two times, with triplicate wells
each time. Data from experiments using XTT as the assay parameter were collected in blocks.
Each block was comprised of n = 6 values derived from of two sets of triplicate values collected
on different days. For the data presented in Figs 2 and 3 statistical analyses were performed as
follows. Each condition had five blocks of data, which were comprised of controls, nonCF Pa,
mucoid Pa and nonmucoid Pa (Pa was either live cells or spent culture filtrates as indicated).
Each block of four conditions was analyzed separately using one-way analysis of variance
(ANOVA) followed by a Tukey’s post-hoc test to adjust for the multiple comparisons being
performed. Prior to pooling, the data in all blocks were verified to be normally distributed and
to have homogenous variances. An initial ANOVA comparison of the five blocks for each
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Fig 2. Pa inhibition of Af during biofilm formation. The data presented show the activity of each live Pa isolate or planktonic- or biofilm-generated Pa
culture filtrate on Af during formation of biofilm by Af. Individual isolate results are shown in comparison with their respective Af controls (n = 6 for each).
There were five non-CF, five mucoid CF and five non-mucoid CF isolates tested; isolate designations are shown on the x-axis. The bars on the far right of
each panel represent the pooled data for each type of isolate (n = 30). Bars represent the mean ± SD of the XTT reduction read at 490 nm. (A) Af conidia
were exposed to live Pa cells for 16 h. (B) Af conidia were exposed to Pa planktonic supernatant for 16 h. (C) Af conidia were exposed to Pa biofilm
supernatant for 16 h. The resulting readings were determined. “XTT metabolic activity” refers to the spectrophotometric absorbance of the formazan
reduction product of XTT at 490 nm. Assays were performed in blocks with two runs of triplicates done on different days, for each Pa-Af combination. Panel
Aspergillus Biofilm and CF Pseudomonas
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condition (e.g., controls) showed the blocks for that condition (e.g., controls) not be signifi-
cantly different. These results allowed us to pool the data for each condition with a result of
n = 30 each. The pooled data were analyzed using one-way ANOVA with a Tukey’s post-test.
For comparisons across live cell versus planktonic or biolfilm supernatants, control values were
first compared and determined to be no different, which was followed by ANOVA and Tukey’s
comparisons of the experimental sets. All statistical analyses were done using GraphPad Prism
(GraphPad Software, Inc. La Jolla, CA). Statistical significance was considered P<0.05.
Results
A summary of all the studies to now be described is in S1 Table. Our primary aim in these stud-
ies was that of a population survey to determine whether Pa from CF or non-CF patients
showed differences in their interactions with Af. Thus we designed studies to assess Pa from
non-CF patients compared with mucoid and nonmucoid Pa from CF patients. Two experi-
mental designs were used. The first was that of the effects of Pa on the development of biofilm
by Af conidia and the second was that of the effects of Pa on preformed Af biofilm. In all of
these studies we assessed the effects of live Pa cells and the effects of spent culture filtrates from
Pa planktonic or biofilm growth and initially relied on the parameter of metabolic activity of
Af, based on XTT reduction. For studies in Figs 2 and 3, five non-CF isolates were selected ran-
domly from the 16 available, and compared to the CF mucoid and non-mucoid isolates.
Inhibition by Pa cells or Pa culture filtrates during Af biofilm formation
The experimental design is shown in Figs 1 and 2, exposing the Af conidia to live Pa cells or fil-
trates for 16 h followed by an additional 24 h of biofilm growth before metabolic assay of XTT
reduction.
Fig 2A summarizes the activity of the Pa cells during Af biofilm formation, as assessed by
metabolic activity. Comparisons of effect of individual isolates of Pa on Af with their respective
Af control showed that each isolate significantly inhibited Af during the formation of Af bio-
film (P<0.001 all comparisons). Pooling of the 5 blocks of data showed that all three groups of
Pa isolates significantly inhibited fungal biofilm formation (each group, P<0.001). Of interest,
these data indicate that the inhibitory effect of CF mucoid Pa or CF non-mucoid isolates was
higher compared to the effect of the non-CF isolates (P<0.001, both comparisons), and CF
non-mucoid cells were more inhibitory than CF mucoid cells (P<0.001).
Fig 2B shows the in vitro activity of culture filtrates from Pa grown under planktonic condi-
tions on the fungal biofilm formation, as assessed by metabolic activity. Comparisons showed
that the planktonic culture filtrates of each individual isolate of Pa significantly inhibited Af
during biofilm formation in comparison with controls (P<0.001). Similarly, the pooled data
showed that the planktonic culture filtrates of each of the three groups of Pa isolates signifi-
cantly inhibited Af (each, P<0.001). The inhibitory effect on Af biofilm formation by the cul-
ture filtrates from CF mucoid or CF non-mucoid Pa isolates was higher compared to the effect
(A) All individual Pa isolates, noted on the x-axis, were significantly inhibitory compared to controls (P<0.001). The four bars on the right side show the pooled
data. CF mucoid and CF non-mucoid cells were more inhibitory than non-CF Pa cells (P<0.001, both comparisons), with CF non-mucoid cells more inhibitory
than CF mucoid cells (P<0.001). Panel (B) Planktonic culture filtrate from all individual Pa isolates, were significantly inhibitory compared to controls
(P<0.001). Pooled data analysis showed both CF mucoid or CF non-mucoid isolate culture filtrate was more inhibitory than that from non-CF isolates
(P<0.001, both comparisons) and non-mucoid was more inhibitory than mucoid (P < 0.001). Panel (C) Culture filtrates from all Pa isolates grown as biofilm
were significantly inhibitory (P<0.001). Pooled data showed culture filtrate from CF non-mucoid isolates under biofilm conditions was more inhibitory than that
from CFmucoid or non-CF isolates under the same conditions (P<0.001, both comparisons), and that non-mucoid CF filtrates were more inhibitory than
mucoid isolate filtrates (P < 0.001).
doi:10.1371/journal.pone.0134692.g002
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Fig 3. Pa inhibition of Af biofilm. The data presented show the activity of each live Pa isolate or planktonic or biofilm generated culture filtrate on preformed
biofilm of Af. Individual isolate results are shown in comparison with their respective Af controls (n = 6 for each). There were five non-CF, five mucoid CF and
five non-mucoid CF isolates tested; isolate designations are shown on the x-axis. The bars on the far right of each panel represent the pooled data for each
isolate (n = 30). Bars represent the mean ± SD of the XTT reduction at read at 490 nm. Panel (A) Af preformed biofilms exposed to live Pa cells for 24 h. (B) Af
preformed biofilms were exposed to Pa planktonic spent supernatant for 24 h. (C) Af preformed biofilms were exposed to Pa biofilm spent supernatant for 24
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of the non-CF filtrates (P<0.001, both comparisons), and culture filtrates from CF non-mucoid
Pa cells were more inhibitory than those from CF mucoid cells (P< 0.001).
The results of incubation of the conidia with culture filtrates obtained from Pa isolates grown
under biofilm conditions are shown in Fig 2C. The culture filtrates of all isolates significantly
inhibited Af attempting to form biofilm as compared to their respective controls (P<0.001, all
comparisons). Examination of the pooled dated showed that biofim culture filtrates of Pa iso-
lates from CF or non-CF patients significantly inhibited the metabolic activity of Af in biofilm
development compared to the controls (all three groups, P<0.001). In addition, culture filtrates
from CF mucoid or non-mucoid Pa isolates were significantly more inhibitory than those from
non-CF isolates (P<0.001, both comparisons); CF non-mucoid Pa isolates biofilm culture fil-
trates were more inhibitory than those frommucoid isolates (P<0.001).
Whereas biofilm formation appears inhibited in the preceding studies, and in CLSM studies
and studies of preformed Af biofilm to be described, we cannot completely rule out that differ-
ences in Af biofilm formation are a result of growth inhibition of the fungus. Studies (described
below) of Pa inhibition of, by contrast, purely planktonic growth of Af, where there were not
significant differences between the three Pa groupings, suggest the inhibitory differences of Pa
groups relates more to the effect on Af biofilm formation.
Effect of live Pa cells or culture filtrates on preformed Af biofilm
The experimental design for these studies is shown in Figs 1 and 3, that of allowing Af to form
biofilm for 16 h and then exposing this biofilm to live Pa or culture filtrates for an additional
24 h before XTT assessment of Afmetabolic activity. Assessment of the inhibitory effects of the
live Pa cells showed that only a single non-CF isolate, Pa19, significantly inhibited the pre-
formed Af biofilm (P<0.01), whereas the other four non-CF isolates had no significant effect
(P>0.05). Compared to preformed Af biofilm controls, all isolates of non-mucoid or mucoid
live Pa from CF patients significantly inhibited the metabolic activity of preformed Af biofilm
(P<0.001). Pooling of the five blocks of data showed that non-CF isolates were not inhibitory,
whereas mucoid Pa isolates and non-mucoid CF isolates significantly inhibited the metabolic
activity of the preformed Af biofilm in comparisons to controls or non-CF isolates of Pa
(P<0.001, both comparisons). Non-mucoid CF isolates were more inhibitory than mucoid CF
isolates (P<0.001) (Fig 3A).
Fig 3B shows the activity of planktonic Pa culture filtrates on preformed Af biofilm. Com-
parisons of individual culture filtrate activity from individual isolates showed that a single non-
CF isolate, Pa19, filtrate was inhibitory (P<0.05), whereas all those from individual filtrates
from non-mucoid or mucoid Pa from CF patients, grown under planktonic conditions, signifi-
cantly inhibited the oxidative metabolism of preformed Af biofilm (P<0.001, all comparisons).
The results of analysis of the pooled data showed non-CF planktonic culture filtrates had no
inhibitory activity, whereas planktonic filtrates from mucoid or non-mucoid Pa isolates were
h. Each data point represents the XTTmetabolic activity obtained spectrophotometrically at 490 nm. Assays were performed in triplicate and the results are
pooled from two experiments for each Pa-Af combination. The asterisk indicates a significant P value (< 0.001) for the XTT metabolic activity compared to the
positive control, using the same analytic methodology as in Fig 2. Panel (A) Individual Pa isolate comparisons showed that only a one non-CF isolate, Pa19,
inhibited (P<0.01), whereas all mucoid or non-mucoid CF isolates were inhibitory (P<0.001, all comparisons). Pooled data analysis showed that both mucoid
and non-mucoid CF isolates were significantly inhibitory (P<0.001, both comparisons) and that non-mucoid CF isolates were more inhibitory than non-CF or
mucoid Pa isolates (P< 0.001, both comparisons). Panel (B) Planktonic spent medium from a single non-CF isolate, Pa19, was inhibitory (P<0.05), whereas
all mucoid and non-mucoid CF were significantly inhibitory (P < 0.001). Pooled data analysis showed that planktonic culture filtrate from CF non-mucoid or
mucoid isolates was inhibitory (P<0.001, both comparisons). Non-mucoid CF isolates were more inhibitory than mucoid CF isolates (P<0.001). Panel (C)
Biofilm culture filtrate from non-CF isolates of Pawas not inhibitory, whereas the culture filtrate from each mucoid or non-mucoid CF Pa isolates was inhibitory
(P< 0.001, all comparisons). Pooled data analysis showed that biofilm culture filtrate from CF non-mucoid or mucoid isolates was inhibitory (P<0.001). Non-
mucoid CF isolate filtrates were more inhibitory than mucoid CF isolates (P<0.001).
doi:10.1371/journal.pone.0134692.g003
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more inhibitory than controls or filtrates from non-CF isolates (P< 0.001, both comparisons).
Non-mucoid CF isolate filtrates were more inhibitory than mucoid CF filtrates (P<0.001).
Fig 3C shows the activity that filtrates from cultures of biofilm-grown Pa isolates had on
preformed Af biofilm. No inhibitory activity was exhibited by the non-CF biofilm filtrates
(P>0.05), whereas all biofilm filtrates from mucoid or non-mucoid CF Pa from CF patients
significantly inhibited preformed Af biofilm, compared to preformed Af biofilm controls
(P<0.001). Similarly, the comparisons of the pooled data showed that non-CF isolate biofilm
filtrates were not inhibitory and both mucoid and non-mucoid isolate biofilm filtrates were
more inhibitory than controls or filtrates of non-CF isolates (P<0.001, both comparisons).
Again, non-mucoid CF isolate biofilm filtrates were more inhibitory than those of mucoid CF
isolates (P<0.001).
Effect of Pa growth on inhibition by Pa supernatants
We felt that the effects of the Pa culture filtrates might plausibly be due to differences in growth
of the Pa isolates, that isolates with better growth could result in more inhibitory compounds
secreted to the culture filtrates. For these and subsequent studies, we chose one representative
isolate from each Pa group (non-CF (Pa19), non-mucoid CF (Pa10) and mucoid CF (Pa11))
(Figs 2 and 3). Each was grown planktonically and the 24 h growth quantitated as described
(Methods). A 106 inoculum of each grew to 3.2 x 108 in the case of the two CF isolates, and 3.3
x 108 for the non-CF isolate. Thus differences in the inhibitory power of the supernatants
appear not explained by differences in growth among these isolates.
Minimal effect of serum on inhibition
Because components of serum can also be present where there is local inflammation, such as in
the airways, to more closely mimic in vivo conditions it is of interest to know whether the inter-
actions described above might be different in the presence of serum. For these studies, serum
was added to the medium in all steps (Fig 1), as indicated in Methods, and all 16 non-CF Pa
isolates were used, as well as the mucoid and non-mucoid CF isolates.
Overall, the results were virtually the same as those from the studies done in the absence of
serum. However, there were exceptions. The Pa live mucoid cells, or the filtrates of such cul-
tures grown planktonically or as Pa biofilm, were, with serum present, not statistically signifi-
cantly inhibitory, as assessed metabolically, to preformed Af biofilm. Specifically, absent that
one exception, the significance and conclusions with (a) mucoid Pa and Af biofilm formation,
or (b) non-CF Pa or non-mucoid CF Pa, as live cells or culture supernatants (the supernatants
from cultures grown planktonically or as Pa biofilm), were the same as the results in the
absence of serum, when tested against either (c) Af biofilm formation or (d) preformed Af bio-
film, Again, non-mucoid Pa isolates were most inhibitory in all conditions, and preformed Af
biofilm the most resistant. None of the 16 non-CF Pa isolates behaved differently than the rest
of that group (data not shown).
In additional experiments (using only the 3 representative Pa isolates, as described in the
preceding section, from each Pa group), we omitted serum from Pa while generating superna-
tants, but added serum during Af biofilm formation or preformed Af biofilm development. We
found the same results, as described, as when serum was present or absent in all phases.
Overall, we conclude that serum is not an important enhancing or decremental factor in Pa
generation of inhibition in supernatants, nor a factor in the effect on Af.
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Comparison of Pa filtrates grown planktonically or as biofilm
All of the studies done with or without serum appeared to indicate that there were differences
in inhibitory activity between Pa planktonic and biofilm supernatants. Because there were few
experiments, at this point, where these two types of Pa filtrates were compared directly to each
other, we approached the comparison, for the studies in Figs 2 and 3, in the statistical fashion
described in the Methods section. For the non-CF and the mucoid CF Pa’s, planktonic and bio-
film supernatants inhibited Af biofilm formation. However, there was no difference between
the planktonic and biofilm culture filtrates from the non-CF Pa, whereas Pa biofilm superna-
tants from mucoid and non-mucoid CF Pa were more inhibitory than planktonic supernatants
(P<0.001, both comparisons). The supernatants of non-mucoid CF Pa were inhibitory to both
Af biofilm formation and preformed Af biofilm, and Pa biofilm supernatants were more inhibi-
tory than planktonic supernatants in both cases (P<0.001 for both comparisons). For compari-
son, a second analysis examined only the studies done in the presence of serum, and with all 16
non-CF isolates. For this second analysis we first compared the controls from each experiment
where Pa isolates had been studied (in which only one type of Pa supernatant was used per
experiment) by one-way ANOVA to assure the Af control results were not different in those
experiments. These analyses showed that there were no significant differences in the Af con-
trols. With this assurance we then compared the inhibition results of the three types of Pa for
the two types of Pa supernatants. This allowed 20 experiments with the non-CF Pa’s and 10
experiments each with mucoid and non-mucoid CF Pa to be studied. The conclusions were the
same as the prior statistical analysis, that of the studies done in the absence of serum.
These statistical differences in planktonic and biofilm Pa filtrates can also be suggested by
visual comparison of Figs 2 and 3, although these differences were more marked when serum
was present. In some subsequent experiments, under special conditions to be described subse-
quently (e.g., comparisons with E. coli), there were direct comparisons of the two kinds of Pa
supernatants, and supernatants from planktonically grown Pa were never more inhibitory than
supernatants from biofilm-grown Pa, regardless of the source of the Pa.
Confocal microscopy analysis
All the preceding studies assessed metabolic effects on biofilm. We now assessed effects on the
physical biofilm itself.
Effects on biofilm thickness
The effect of the Pa spent culture filtrates on Af biofilm thickness and morphology were assessed
using CLSM. The thickness results for the Af biofilm after conidia exposure for 16h to the Pa
spent supernatants from the representatives of all three bacterial phenotypes are shown (Fig 4).
The spent supernatant obtained from all three Pa phenotypes, after Pa growth planktonically or
as biofilm, resulted in a significant reduction of the fungal biofilm thickness compared to the
untreated control (Fig 4A and 4B). Treatment with the spent supernatants from the non-CF
and the CF mucoid isolates had no significant effect on the thickness measurements of pre-
formed Af biofilm, whereas the supernatant of the non-mucoid Pa, grown either planktonically
or as biofilm, was inhibitory (Fig 4C and 4D).
Effects on Af biofilm formation
Untreated biofilms showed an architecture formed by a dense filamentous multicellular struc-
ture with acute-angle dichotomous branching (Figs 5A and 6A). The Pa supernatants’ effect on
Af biofilm was also observed in the morphology studies using CLSM. Fig 5B, 5C and 5D show
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the effect of Pa culture filtrates on Af biofilm formation. Non-CF Pa spent supernatant, from
Pa grown as biofilm, resulted in reduction in filamentation and presence of some “glued”
hyphae, without a clear separation of the filamentous elements. A similar morphology pattern
was observed when the conidia were treated with planktonic culture filtrates from the same
strain (data not shown). Treatment with culture filtrates from the CF mucoid strain culture,
grown under biofilm condition, resulted in decreased number of hyphae and presence of some
"bulging" structures (possibly conidial remnants) distributed throughout the disperse filaments,
and “glued” hyphae (Fig 5C). The CF non-mucoid Pa biofilm filtrate resulted in severe effects
on hyphal structure, with loss of filamentation, and hyphal tips or branch points appeared to
be thin. Several bulges and deposition of amorphous material were also observed. Treatment
with planktonic spent supernatant from the CF non-mucoid isolate was associated with a
Fig 4. Pa supernatant affects Af biofilm thickness. Af biofilms were formed and stained as described. Sections of the xy plane were taken at 1 μm
intervals along the z-axis to determine the depth of the biofilms. (A) Af conidia were exposed to planktonic Pa spent supernatant or (B) biofilm Pa spent
supernatant, for 16 h. (C) Af preformed biofilms were exposed to planktonic Pa spent supernatant or (D) biofilm Pa spent supernatant, for 24 h. Assays were
performed in triplicate and images were taken from three different fields from each sample. The results are representatives of two different experiments for
each Pa-Af combination. One asterisk indicates a P value (<0.01), and two asterisks indicates a P value (<0.001) for the biofilm thickness compared to the
untreated control.
doi:10.1371/journal.pone.0134692.g004
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disruption of the hyphae structure and presence of surface collapse and glued filaments (data
not shown).
Effects on preformed biofilm
As was suggested by the biofilm thickness data, treatment of preformed Af biofilm with the
spent supernatants from the non-CF and the CF mucoid isolates were not associated with
important morphology changes (Fig 6B and 6C). There was a prominent morphology change
observed comparing the untreated Af control and treatment with the CF non-mucoid Pa strain
grown under biofilm conditions (Fig 6D). We observed severe effects on hyphal structure, with
loss of filamentation, and hyphal tips and branch points appeared to be thin after the treat-
ment. Moreover, we observed amorphous structures distributed throughout the intertwined
defective filamentous networks.
Fig 5. CLSM images of Af biofilm after challenging conidia for 16h with biofilm Pa spent supernatant.
Horizontal (xy) view of reconstructed 3-dimensional images of FUN1-stained biofilms, with filter set to capture
green fluorescence. Thickness of the biofilm can be observed in the side view of the reconstruction (extreme
right and lower panels in each picture). (A) Untreated control. (B) Af conidia exposed to spent supernatant of
a non-CF Pa grown as biofilm for 16 h, or (C) exposed to mucoid CF Pa biofilm spent supernatant or (D)
exposed to non-mucoid CF Pa biofilm spent supernatant. Arrows show “bulge-like” structures and deposition
of amorphous material in treated cultures. Magnification, ×63. Bar, 50 μm.
doi:10.1371/journal.pone.0134692.g005
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MW characterization of the inhibitors in filtrates
To better understand the nature of the inhibitor(s) present in the Pa filtrates, we performed a
series of studies to assess their physical and chemical nature.
To determine whether the inhibitors in filtrates were related to small molecular species, a
sample of inhibitory filtrate from the non-mucoid Pa biofilm culture was passed through an
ultrafilter that now excluded all materials>30,000 MW, and tested against Af conidia forming
biofilm, in comparison to the same filtrate not further manipulated (as in Fig 1III). These two
samples inhibited Af biofilm formation (P<0.001), and were not different from each other. We
conclude that the inhibitory component(s) in Pa filtrates appear to be<30,000 MW species.
Fig 6. CLSM images of Af biofilm after challenging preformed Af biofilm for 24 h with Pa biofilm spent
supernatant. Horizontal (xy) view of reconstructed 3-dimensional images of FUN1-stained biofilms, with filter
set to capture green fluorescence. Thickness of the biofilm can be observed in the side view of the
reconstruction (extreme right and lower panels in each picture). (A) Untreated control. (B) Af preformed
biofilm exposed to spent supernatant of a non-CF Pa biofilm spent supernatant for 16 h or (C) exposed to
mucoid CF Pa biofilm spent supernatant or (D) exposed to non-mucoid CF Pa biofilm spent supernatant.
Arrows show the amorphous structures distributed throughout the intertwined altered filamentous networks in
treated cultures. Magnification, ×63. Bar, 50 μm.
doi:10.1371/journal.pone.0134692.g006
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Specificity
As a brief inquiry into the specificity of the culture filtrates of Pa inhibiting Af, we grew E. coli
ATCC 43888 under identical conditions as we had the Pa isolates, and collected these filtrates
in the same manner. Supernatant from the non-mucoid Pa was included in these experiments
as a positive control. The filtrates of the E. coli, either grown planktonically or as biofilm, did
not significantly inhibit Af conidia forming biofilm (conditions under which, in contrast, all Pa
filtrates tested could inhibit; see Fig 2), and the positive Pa control filtrate did significantly
inhibit. The filtrates of the E. coli, either grown planktonically or as biofilm, also did not inhibit
preformed Af biofilm (data not shown).
To ascertain whether the reference Af isolate, 10AF, was representative, three and nine
other non-CF Af isolates were tested, by challenging formation of Af biofilm from their conidia,
or preformed Af biofilm, respectively (Fig 1II and 1IV, respectively), by live Pa cells of the non-
mucoid CF Pa. Isolate 10AF was assayed concurrently. The XTT activity of all untreated Af
biofilms formed were not significantly different, and all were markedly inhibited (P<0.001) by
the addition of the Pa cells (data not shown).
We conclude that not all bacteria produce compounds that are inhibitory to Af biofilm and
that the inhibition by Pa is not unique to our reference strain of Af.
The effect of Pa culture filtrates on Af is a result of inhibitors in filtrates,
not reduction of nutrients
We addressed the possibility that the inhibition of Af biofilm by the Pa filtrates would be due
to a reduced nutritional value of the spent culture filtrates diluting out the value of newly
added medium during the incubation phase in the Af biofilm assays. The effect of fresh RPMI
diluted with Pa culture filtrates (from biofilm-grown Pa) or sterile distilled water (a milieu
that offers no nutrient support) on Af biofilm formation was studied. Fungal biofilm meta-
bolic activity was inhibited over a range of ratios of fresh RPMI diluted with culture filtrates
obtained from the representative CF and non CF Pa isolates, with inhibition starting at as lit-
tle as 20% filtrate (80% fresh RPMI) (P<0.05) (Fig 7A). In contrast, Af biofilms were not sig-
nificantly affected after challenge with fresh RPMI diluted in distilled water until the mixture
contained only a 20% fresh RPMI concentration (80% distilled water) (Fig 7A); this concen-
tration of RPMI is much lower than that of the 50% fresh RPMI dilution with filtrates as used
in the supernatant experiments previously described (Figs 2 and 3). These findings indicate
that the presence of inhibitory products in Pa culture filtrates were responsible for the inhibi-
tion of the metabolic activity of the fungal biofilms, rather than the inhibition being due to
dilution of the nutrients in media by addition of Pa culture filtrate, or removal of the nutrients
from the growth media during the Pa growth; i.e., that the inhibition by culture filtrate of Pa
is a result of substances (<30,000 MW) Pa secretes into the culture filtrate, rather than nutri-
ents removed by Pa.
Although this paper is focused on Af biofilm, it was of interest, for comparison, to see the
effect of Pa supernatants on Af growing planktonically, as would occur in tubes, as in classical
susceptibility testing [52]. The representative isolates from each of the three Pa groups was
studied. When Pa supernatant was diluted in medium 1:1, exactly as in the challenges of bio-
film, applied to Af conidia inocula in tubes, and the tubes examined when hyphal growth in
matched controls was 4+, visible Af growth in the presence of supernatants did not occur (i.e.,
0 growth in the supernatants of the CF isolates, or trace growth in that of the non-CF Pa). To
again assure the inhibition seen was a result of toxic factors from the Pa, rather than depletion
of media by Pa growth, the dilution series experiment with distilled water was repeated as
above (Fig 7B). The result was even more dramatic than seen with Af biofilm targets: any
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concentration of supernatant10% (i.e.,90% fresh medium) reduced the planktonic growth
metabolic activity by XTT virtually completely, whereas it was only when the concentration of
distilled water reached 40% (only 60% fresh medium) that any effect at all was seen on that
XTT result (Fig 7B). The effect was modestly larger with the non-mucoid CF Pa, but was not
statistically significantly greater than the inhibition seen with the supernatants of the other two
Pa isolates.
Effect of temperature on Pa supernatants
Two experiments were performed on heat treatment of the Pa filtrates (from planktonic or bio-
film cultures), using the 3 representative isolates detailed, and (a) in the absence of serum from
all steps or (b) just during the generation of supernatants. Comparison was made to untreated
filtrates.
The heat treatment of the supernatants of all 3 Pa isolates, under both test conditions “(a)”
and “(b)”, removed all inhibitory activity against Af forming biofilm or preformed Af biofilm,
i.e., heated supernatant results same as controls (data not shown). There was one small excep-
tion: the non-mucoid CF strain heated supernatant retained significant inhibitory activity
against Af forming biofilm, but not against preformed Af biofilm, only when the filtrate was
from the Pa biofilm (not planktonic Pa) culture, and only in condition “(b)”.
In another experiment, freeze-thawed supernatant of the non-mucoid CF isolate, either
grown planktonically or as biofilm, retained inhibitory activity against Af forming biofilm
(both P<0.001 compared to untreated Af control), but this was significantly diminished com-
pared to untreated supernatants (both P<0.001). When either frozen-thawed supernatant was
tested against preformed Af biofilm, all activity was lost.
Fig 7. A. Pa biofilm supernatant inhibits Af biofilm formation. Af conidia were exposed to serial dilutions of Pa spent medium or sterile distilled water,
mixed with fresh RPMI supplemented with 10% serum during Af biofilm formation as described in Methods and Fig 1III. The percent of fresh medium in each
test situation was decreased as the spent medium or sterile distilled water increased. Then the resulting XTT readings were quantified, and the results
expressed as percent of control with medium alone (no supernatant or distilled water). Results are presented as the mean of three replicates from three
strains of Pa performed on two separate occasions. Error bars represent the SD of the mean.B. Pa biofilm supernatant inhibits planktonic Af. Af conidia
were exposed to serial dilutions of Pa spent medium or sterile distilled water, mixed with fresh RPMI, and grown planktonically in tubes, as described in
Methods. The percent of fresh medium in each tube was decreased as the spent medium or sterile distilled water increased. Then the resulting XTT readings
were quantified, and the results expressed as percent of control with medium alone (no supernatant or distilled water). The results shown are with the non-
mucoid CF Pa isolate supernatant; the mucoid CF Pa isolate and the non-CF Pa isolate were studied concurrently, and the results were not different; only the
non-mucoid Pa result is shown to avoid clutter.
doi:10.1371/journal.pone.0134692.g007
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We conclude that the heat treatment used removed essentially all Af-inhibitory activity
from supernatants of all types of Pa isolates. Freeze-thawing significantly diminishes inhibitory
activity.
Effect of DNase I and proteinase K on Pa biofilm culture filtrate activity
To determine whether the inhibitory substances were protein or DNA, we treated a nonmucoid
Pa culture filtrate with DNAase or proteinase prior to assay for inhibitory activity. Compared
to untreated Pa filtrate, filtrate treated with DNase I showed no significant differences in inhib-
itory capacity compared to Af control, nor did the DNase I alone have an inhibitory effect
(data not shown).
EDTA (a chelator of metal anions, such as Fe; and a component of the DNase assay) alone
reduced the metabolic activity of Af biofilm compared to Af biofilm untreated controls
(P<0.001). The EDTA inhibitory effect was less than that of untreated Pa filtrate. EDTA
+ DNase I did not affect inhibition of Af biofilm by Pa filtrate. Finally, DNase I had no effect
on EDTA inhibition of Af biofilm, as there were no significant differences between EDTA and
DNase I + EDTA.
Proteinase K alone did not affect Af biofilm formation. The addition of Proteinase K to Pa
filtrates did not affect filtrate inhibition of Af biofilm formation.
Other characterization of Pa isolates
Because of the differences we observed among the Pa types tested, we also tested for some phe-
notypes previously associated with Pa virulence. Elastase activity, a virulence factor in Pa [57],
was assessed in the Pa isolates that were used in the Af biofilm studies. The 5 non-mucoid CF
isolates more frequently showed a positive test compared to the 5 mucoid CF and 5 non-CF
isolates (3 vs. 2 and 1, respectively, at 24 hrs.; 5 vs. 3 and 3 at 48 hrs. with additional incubation
at 4°C).
Certain Pa colonial types have been associated with lasR gene (a “master” gene controlling
Pa virulence genes) mutations, more severe lung disease and persistence despite eradication
attempts, including a wrinkly colony surface, irregular colony edge, metallic sheen, and green
colony color [58]. As with elastase, these characteristics were also not significantly associated
with our three groups differing in Af inhibition; 2 or 3 (of 5) of the non-mucoid isolates had
each of these characteristics, compared to 1 to 3 of the other groups of 5 in each instance.
Role of iron in inhibition by Pa filtrates
Iron is a co-factor required for growth and both Af and Pa produce siderophores to acquire
iron for their needs. Three experiments were performed to confirm a possible role for iron
sequestration by Pa filtrates in the inhibition of Af. A filtrate of the inhibitory non-mucoid Pa,
grown under biofilm conditions, was tested (schema as in Fig 1V) alone or with added FeCl3,
at 3-fold increasing concentrations from 11 μM through 297 μM, then 10-fold increasing con-
centrations from 300 μM through 30 mM, against Af forming biofilm, and compared to the
usual control (RPMI without filtrate) (Fig 8). In combinations with filtrate, from 11 to 300 μM
FeCl3, inhibition by the filtrate was retained, and without significant difference from the inhibi-
tion by filtrate in the absence of FeCl3 (P<0.001 for inhibition by all, compared to no-filtrate
control). At 3000 μM FeCl3, there was no significant inhibition compared to control Af, and
the inhibition was significantly less (P<0.001) than that with the filtrate without FeCl3. At 30
mM FeCl3 the XTT result showed not only lack of inhibition, but was significantly enhanced
compared to both the filtrate-free control and filtrate without added FeCl3.
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In separate studies on FeCl3 alone, reported preliminarily elsewhere [59], we have found, as
in Fig 8, FeCl3 alone at2500 μM to enhance Af biofilm XTT activity. The enhancement of
growth in the present study, with 3000 μM FeCl3 alone, compared to partial inhibition by the
same concentration combined with filtrate, confirms the dose-responsive reversal of inhibition
by filtrate shown in Fig 8.
We conclude, from the iron reversal of Pa supernatant inhibition, that iron sequestration,
such as in the form of Pa siderophores or other Pa iron-binding molecules [60], is at least part
of the mechanism of the inhibition of Af biofilm by Pa filtrates.
Discussion
Whereas planktonic Af growth appears affected by any Pa isolate, and the inhibition is more
intense than on Af biofilm growth, we show that the described inhibition of Af biofilm by Pa
[42–45] is related to the source and phenotype of the Pa isolate. Titration studies may have elu-
cidated differences, among Pa types, in inhibition by supernatants on planktonic Af growth,
but we chose not to pursue this. The differential effects of Pa types on Af biofilm is consistent
with the extensive phenotypic and genomic changes in the mutable Pa organism that, associ-
ated with chronic residence in CF airways, have been described [2,8,9,61]. Specifically, we show
live Pa cells inhibit the growth and formation of Af biofilm, with CF Pa isolates more inhibi-
tory, and non-mucoid CF Pa isolates most inhibitory. Inhibition did not require the presence
Fig 8. The effect of FeCl3 on the inhibition of Af biofilm formation, by filtrate from a CF non-mucoid Pa grown under biofilm conditions. Conidia
formed biofilms on polystyrene disks (AF) during 16 h exposure to Pa filtrate (PA), filtrate + varying concentrations of FeCl3 (shown as the concentration, uM
= μM), or varying concentrations of FeCl3 only. After 16 h of challenge, disks were transferred to fresh RPMI-1640 for 24 h of further growth before biofilm
formation was quantified via XTT assay, and the results expressed as percent of control with medium alone (no supernatant or FeCl3). Asterisks denote P
<0.001 for comparisons to the experimental control containing Af with RPMI-1640 (AF; no test materials). Daggers denote P <0.001 for comparisons with the
experimental control containing Af +filtrate (AF + PA). Results with AF + PA + 11, 33 or 99 μM FeCl3 were not different than AF + PA; AF + 11, 33, or 99 μM
FeCl3 were not different than AF + 297 μM FeCl3; and these results are not shown.
doi:10.1371/journal.pone.0134692.g008
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of Pa cells, as Pa culture filtrates were also inhibitory. The inhibition by filtrates showed the
same hierarchy, with CF Pa isolates more inhibitory, and non-mucoid Pa isolates most inhibi-
tory. Preformed Af biofilm was more resistant to Pa; non-mucoid CF Pa isolates were most
inhibitory, and, again, that inhibition could be reproduced with culture filtrates. Reproducibil-
ity of the three Pa groupings was assured by the repeated experiments of various conditions,
utilizing representative isolates of the groupings, as well as the number of isolates studied.
Moreover, selection of Pa19, the most inhibitory of the non-CF isolates, as the representative
of that group, would have minimized the differences in these studies between the CF and non-
CF isolates.
Inhibition of Af biofilm appears dependent on the bacterial growth conditions, since filtrates
from Pa grown as biofilm were more inhibitory than from Pa grown planktonically. However,
the relationship of the number of Pa cells at the end of biofilm growth vs. the number after
planktonic growth is unknown. Differences in biological effect on mammalian cells for mole-
cules produced by planktonic Pa vs. biofilm Pa have previously been described, although
planktonic Pa in that study produced more such active molecules [19]. We have assumed the
production of substances with different Af-inhibitory power by the three Pa groupings is unre-
lated to the growth of the Pa, based on our growth studies by representative isolates of each
group. However, each of the groups studied may be heterogenous, and more extensive studies,
with more members of each group, might then show a relationship between growth and super-
natant inhibition.
We chose to measure Af inhibition by the XTT assay of metabolism (which does not
exclude the possibility of death of some Af cells), because of the controversies in interpreting
CFU reduction in a multinucleate filamentous organism, commonly with incomplete septa
between cells [62,63]. Such problems are magnified when attempting to quantitate a biofilm
network [64]. However, others have indicated Af is, in fact, killed by Pa [64]. The XTT results
would also not exclude a switch by the fungus to non-oxidative, fermentative, metabolism.
However, our photomicrographs, and measurements of biofilm thickness, support the con-
cept of actual growth inhibition occurring. The effects we describe on preformed Af biofilm
show that Pa effects on Af are not solely on inhibition of the initial adhesion stage of Af bio-
film development.
Previous work has indicated many candidate Pamolecules that can explain the various inhi-
bitions we have described [42–47]. We confirm that small Pa-derived molecules, probably not
nucleic acids or proteins per our studies, can explain at least most of the inhibition in superna-
tants. Whereas most previous work has focused on the toxic effects of Pametabolites on fungi,
our work suggests that denial of Fe to Af by Pa products is an important part of the inhibition.
This is in contrast to a study of Pa inhibition of Candida albicans, which concluded that inhibi-
tion of that fungus was not a result of Fe limitation [46], although these apparent fungal differ-
ences could be affected by different experimental conditions. The bacterial-fungal interplay is
more complex than just molecules produced by Pa, as recent elegant work has shown that Af
can transform Pametabolites, and thus radically alter the effect on the interaction, including
the degree of inhibition [65]. Finally, Fe limitation by Pa could also in part be a result of modu-
lation of Af siderophore production by Pametabolites [66].
Pa quorum-sensing systems control expression of virulence factors, such as those previously
implicated in Af inhibition [42–47]. A study that indicated no difference in quorum-sensing
between CF and non-CF Pa isolates [67] might suggest that quorum sensing-induced mole-
cules are at least not solely responsible for the increased inhibitory activity we have described
for CF non-mucoid isolates. Some phenotypic factors previously associated with Pa virulence
[57,58] that we studied did not appear associated with Af inhibition.
Aspergillus Biofilm and CF Pseudomonas
PLOSONE | DOI:10.1371/journal.pone.0134692 August 7, 2015 22 / 27
Our findings contrast with others, who reported Af biofilm was not inhibited by Pa [45], a
difference likely attributable to their lack of study of CF Pa isolates. Our findings also contrast
with the report of heat-resistance of Af-inhibitory factors produced in Pa cultures [45], since
we show lability of essentially all the inhibition to heat, as well as significant lability to a freeze-
thaw cycle. Such study differences could be a result of different Pa and Af culture and/or heat-
ing conditions. These differences support the value of detailing the physical and chemical char-
acterizations of the supernatants described here; these characterizations could lead to further
identification of the molecules responsible for the inhibition we have described. Another path-
way to this end would be to utilize the many Pa virulence factor mutants [68] that have been
described (studies in progress).
A limitation of our studies is that we have only studied one time period, although one ade-
quate for bacterial growth, for production of Pa factors, whereas different regulatory systems
may have different kinetics [68]. It may be of interest to study earlier and later time periods
of Pa culture, and assess whether inhibitory factors are produced to a greater or lesser extent.
We also cannot state at this time whether the enhanced inhibitory activity by biofilm Pa com-
pared to planktonic Pa culture filtrates, or that resulting from non-mucoid CF isolates and
their filtrates, is owing to increased production of inhibitory factors, or possibly the produc-
tion of different factors. Nor is it known whether the inhibition by live cells relies solely on
the same inhibitory factors (factors which can be released by Pa cells in close proximity to Af
without dilution in culture medium) as in supernatants or whether there are unique factors
resulting from or triggered by microbial contact. In this regard, the apparent greater inhibi-
tory activity of live cells compared to supernatants (e.g., Fig 2) could be related to the obser-
vation that Pa production of virulence factors can be increased by co-culture with some other
microbes [69]. It would also be of interest to study prolonged mixed Pa-fungal biofilm devel-
opment [64], since the mixed condition is only beginning in our studies of Af forming biofilm
challenged with Pa cells. Another issue is that CF patients in proximity to each other can
cross-infect Pa isolates [70]; moreover, one Pa clone can therefore come to dominate in
patients in one clinic-hospital setting [71]. Thus, without detailed sequencing data, one can-
not be sure isolates from multiple CF patients in the same setting are not all very closely
related; our observations should be confirmed with isolates from other centers. Finally, a
population study, similar to that which we have done for Pa, would be of interest with respect
to CF Af isolates, and whether any differ from non-CF, or reference Af, isolates (studies in
progress).
Individual patient samples in our cohort shows not only that Pa isolates of varying colonial
phenotype can co-exist in the same patient, but isolates with varying Af-inhibitory properties
can co-exist; such polymorphism could be a transition state in the evolution of Pa colonization.
Overall, from our studies of different Pa phenotypes, we hypothesize the transition of Pa from
non-mucoid to mucoid [72–75], a process that usually occurs with time in CF disease, with the
latter moving to a deeper zone of the lung [75], ablates Pa’s inhibitory effect on Af biofilm, and
thus, helps explain why establishment of Af in the airways usually occurs later in CF disease.
Evolution of Pamay act in concert with other factors favoring Af colonization [76], including
repeated antibacterial courses.
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